Market Tracker

04/21 5:16pm ET

Alimera Sciences Inc (NASDAQ:ALIM)

1.40
Delayed Data
As of Apr 21
 +0.01 / +0.72%
Today’s Change
1.01
Today|||52-Week Range
5.15
+29.63%
Year-to-Date
No recent news for Alimera Sciences Inc.

Today’s Trading

Previous close1.39
Today’s open1.37
Day’s range1.35 - 1.43
Volume237,487
Average volume (3 months)541,071
Market cap$90.8M
Dividend yield--
Data as of 3:59pm ET, 04/21/2017

Growth & Valuation

Earnings growth (last year)+8.70%
Earnings growth (this year)+81.75%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)+53.01%
P/E ratioNM
Price/Sales1.66
Price/Book--

Competitors

 Today’s
change
Today’s
% change
MSLIMerus Labs Internati...+0.01+0.89%
SRNESorrento Therapeutic...+0.10+5.88%
CTRVContraVir Pharmaceut...-0.09-6.00%
AFMDAffimed NV-0.17-7.78%
Data as of 3:59pm ET, 04/21/2017

Financials

Next reporting dateMay 11, 2017
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$34.3M
Annual profit (last year)-$33.2M
Net profit margin-96.62%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Charles Daniel Myers
President &
Chief Financial Officer
Richard S. Eiswirth
Corporate headquarters
Alpharetta, Georgia

Forecasts